Could a Weight-Loss drug curb alcohol cravings? new brain study investigates

This study looks at whether tirzepatide, a drug used for diabetes and weight loss, can change how the brain responds to alcohol-related cues in people with alcohol use disorder (AUD). Researchers will use brain scans to measure dopamine activity in healthy volunteers and people with AUD after taking tirzepatide or a placebo. The goal is to understand how the drug affects brain chemistry, not to treat the disorder directly.